Bystander memory T cells and IMiD/checkpoint therapy in multiple myeloma: A dangerous tango?
Sponaas, Anne-Marit; Waage, Anders; Vandsemb, Esten; Misund, Kristine; Børset, Magne; Sundan, Anders; Slørdahl, Tobias Schmidt; Standal, Therese
Peer reviewed, Journal article
Published version
![Thumbnail](/ntnu-xmlui/bitstream/handle/11250/2738243/Sponaas%2b2021%2bFrontiers.pdf.jpg?sequence=6&isAllowed=y)
Åpne
Permanent lenke
https://hdl.handle.net/11250/2738243Utgivelsesdato
2021Metadata
Vis full innførselSamlinger
- Institutt for klinisk og molekylær medisin [3554]
- Publikasjoner fra CRIStin - NTNU [38278]
- St. Olavs hospital [2536]
Sammendrag
In this review article we discuss the role of the memory T cells in multiple myeloma (MM) and how they may influence immune responses in patients that received immunomodulating drugs and check point therapy